Samer Hanna

Samer Hanna, PhD, is a Senior Scientist at Boehringer Ingelheim since June 2022, previously serving as an NIH/NCI K00 Postdoctoral fellow at Weill Cornell Medicine from September 2018 to June 2022. Prior to this, Samer was a PhD candidate at Albert Einstein College of Medicine, where involvement as an NIH/NCI F99 fellow spanned from August 2012 to August 2018. Education includes a Doctor of Philosophy (Ph.D.) in Cell/Cellular and Molecular Biology and a Master of Science in Biomedical Sciences from Albert Einstein College of Medicine, as well as a Master of Science in Molecular Biology from Lebanese American University. Initial academic foundations were laid at Notre Dame University - Louaize, earning a Bachelor of Science in Biology.